TrialCancer2017
Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trial.
Dan P Stark et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this paperpooled itcites it
TrialCancer2017
Dan P Stark et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.